Trial Profile
A Randomized Double Blind Placebo Control Trial of Milnacipran for Migraine Pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2022
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Headache; Migraine
- Focus Therapeutic Use
- 01 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Oct 2013 Planned end date changed from 1 May 2012 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 10 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.